Targeting 3CLpro and SARS-CoV-2 RdRp by Amphimedon sp. Metabolites: A Computational Study

被引：6
|
作者：
Shady, Nourhan Hisham [1 ]
Hayallah, Alaa M. [2 ,3 ]
Mohamed, Mamdouh F. A. [4 ]
Ghoneim, Mohammed M. [5 ,6 ]
Chilingaryan, Garri [7 ,8 ]
Al-Sanea, Mohammad M. [9 ]
Fouad, Mostafa A. [10 ]
Kamel, Mohamed Salah [1 ,10 ]
Abdelmohsen, Usama Ramadan [1 ,10 ]
机构：
[1] Deraya Univ, Fac Pharm, Dept Pharmacognosy, New Minia City 61111, Egypt
[2] Assiut Univ, Fac Pharm, Dept Pharmaceut Organ Chem, Assiut 71526, Egypt
[3] Sphinx Univ, Fac Pharm, Pharmaceut Chem Dept, New Assiut 71515, Egypt
[4] Sohag Univ, Fac Pharm, Dept Pharmaceut Chem, Sohag 82524, Egypt
[5] AlMaarefa Univ, Coll Pharm, Dept Pharm Practice, Ad Diriyah 13713, Saudi Arabia
[6] Al Azhar Univ, Fac Pharm, Dept Pharmacognosy, Cairo 11371, Egypt
[7] NAS RA, Inst Mol Biol, Yerevan 0014, Armenia
[8] Russian Armenian Univ, Inst Biomed & Pharm, Yerevan 0051, Armenia
[9] Jouf Univ, Coll Pharm, Dept Pharmaceut Chem, Aljouf 72341, Saudi Arabia
[10] Minia Univ, Fac Pharm, Dept Pharmacognosy, Al Minya 61519, Egypt
来源：
MOLECULES | 2021年 / 26卷 / 12期
关键词：
COVID-19; coronavirus; molecular docking; Amphimedon sp; sponge; ANTICANCER ACTIVITY; NATURAL-PRODUCTS; INHIBITORS; DESIGN; PROTEASE;
D O I：
10.3390/molecules26123775
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Since December 2019, novel coronavirus disease 2019 (COVID-19) pandemic has caused tremendous economic loss and serious health problems worldwide. In this study, we investigated 14 natural compounds isolated from Amphimedon sp. via a molecular docking study, to examine their ability to act as anti-COVID-19 agents. Moreover, the pharmacokinetic properties of the most promising compounds were studied. The docking study showed that virtually screened compounds were effective against the new coronavirus via dual inhibition of SARS-CoV-2 RdRp and the 3CL main protease. In particular, nakinadine B (1), 20-hepacosenoic acid (11) and amphimedoside C (12) were the most promising compounds, as they demonstrated good interactions with the pockets of both enzymes. Based on the analysis of the molecular docking results, compounds 1 and 12 were selected for molecular dynamics simulation studies. Our results showed Amphimedon sp. to be a rich source for anti-COVID-19 metabolites.
引用
收藏
页数：15
相关论文
共 50 条
  • [31] Identification of Vitamin K3 and its analogues as covalent inhibitors of SARS-CoV-2 3CLpro
    Wang, Ruyu
    Hu, Qing
    Wang, Haonan
    Zhu, Guanghao
    Wang, Mengge
    Zhang, Qian
    Zhao, Yishu
    Li, Chunyu
    Zhang, Yani
    Ge, Guangbo
    Chen, Hongzhuan
    Chen, Lili
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2021, 183 : 182 - 192
  • [32] Chlorogenic acid may be a potent inhibitor of dimeric SARS-CoV-2 main protease 3CLpro: an in silico study
    Patil, Rajkumar Sanjay
    Khatib, Nayeem A.
    Patil, Vishal Shivalingappa
    Suryawanshi, Shailendra Sanjay
    TRADITIONAL MEDICINE RESEARCH, 2021, 6 (02):
  • [33] A new glimpse on the active site of SARS-CoV-2 3CLpro, coupled with drug repurposing study
    Novak, Jurica
    Potemkin, Vladimir A.
    MOLECULAR DIVERSITY, 2022, 26 (05) : 2631 - 2645
  • [34] Exploration of chalcones as 3-chymotrypsin-like protease (3CLpro) inhibitors of SARS-CoV-2 using computational approaches
    Thua-Phong Lam
    Dac-Nhan Nguyen
    Tan Thanh Mai
    Thanh-Dao Tran
    Minh-Tri Le
    Phuong Nguyen Hoai Huynh
    Duc-Tuan Nguyen
    Viet-Hung Tran
    Dieu-Thuong Thi Trinh
    Phuong Truong
    Cam-Van T. Vo
    Khac-Minh Thai
    Structural Chemistry, 2022, 33 : 1707 - 1725
  • [35] Natural Products-Based Drug Design against SARS-CoV-2 Mpro 3CLpro
    Silva, Rai C.
    Freitas, Humberto F.
    Campos, Joaquin M.
    Kimani, Njogu M.
    Silva, Carlos H. T. P.
    Borges, Rosivaldo S.
    Pita, Samuel S. R.
    Santos, Cleydson B. R.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (21)
  • [36] Virtual screening and molecular dynamics simulation analysis of Forsythoside A as a plant-derived inhibitor of SARS-CoV-2 3CLpro
    Bibi, Shabana
    Khan, Muhammad Saad
    El-Kafrawy, Sherif A.
    Alandijany, Thamir A.
    El-Daly, Mai M.
    Yousafi, Qudsia
    Fatima, Dua
    Faizo, Arwa A.
    Bajrai, Leena H.
    Azhar, Esam I.
    SAUDI PHARMACEUTICAL JOURNAL, 2022, 30 (07) : 979 - 1002
  • [37] Label-free duplex SAMDI-MS screen reveals novel SARS-CoV-2 3CLpro inhibitors
    Scholle, Michael D.
    O'Kane, Patrick T.
    Dib, Sandra
    Gurard-Levin, Zachary A.
    ANTIVIRAL RESEARCH, 2022, 200
  • [38] Reconstruction of the unbinding pathways of noncovalent SARS-CoV and SARS-CoV-2 3CLpro inhibitors using unbiased molecular dynamics simulations
    Tiyoula, Fereshteh Noroozi
    Aryapour, Hassan
    PLOS ONE, 2022, 17 (02):
  • [39] In silico evaluation of antiviral activity of flavone derivatives and commercial drugs against SARS-CoV-2 main protease (3CLpro)
    Merzouki, Mohammed
    Challioui, Allal
    Bourassi, Lamiae
    Abidi, Rania
    Bouammli, Boufelja
    El Farh, Larbi
    MOROCCAN JOURNAL OF CHEMISTRY, 2023, 11 (01): : 129 - 143
  • [40] Assessment of activity of chalcone compounds as inhibitors of 3-chymotrypsin like protease (3CLPro) of SARS-CoV-2: in silico study
    Shalini Mathpal
    Tushar Joshi
    Priyanka Sharma
    Veena Pande
    Subhash Chandra
    Structural Chemistry, 2022, 33 : 1815 - 1831
12345